Clinical Study for Obstructive Sleep Apnea and Excess Weight

Researchers are studying an investigational injectable medication to see whether it can help improve symptoms of obstructive sleep apnea (OSA) in adults who are also living with obesity. Take the survey to find out if you prequalify.

Take the survey

Who can take part?

Living with OSA can mean constant fatigue, disrupted sleep, and feeling like nothing truly helps. These studies are designed for adults who may be seeking new options and want to help advance future treatment possibilities.

You, or someone you care for, may be able to take part if you/they:

are 18 years of age or older
have been diagnosed with moderate to severe obstructive sleep apnea (OSA)
are obese (have a BMI of 27 or higher)

Inclusive research helps lead to better treatments for everyone. This study encourages participation from individuals across different communities, backgrounds, and experiences to help ensure results reflect the full range of people living with obstructive sleep apnea.

Take the survey

What will this study involve?

This study will last up to 88 weeks (a little under 2 years), including screening and follow-up visits. Participants receive all study-related care at no cost from trained doctors and healthcare providers.

The investigational medication or placebo is given by subcutaneous injection every 4 weeks. At the end of 52 weeks, patients receiving the placebo will be switched to the study drug - so all participants will receive the study medication.

Several overnight sleep studies (PSG) will take place throughout the trial to measure OSA severity and track changes.

Participants will complete brief questionnaires about sleep quality, fatigue, and daily functioning at multiple visits.

Take the Survey

To find out if you prequalify, take the survey below. You'll get your results instantly. Should you prequalify, our study support team will reach out to help you with the next step.